ArticleMayo Clinic proceedings. Innovations, quality & outcomes2025
Dynamic Changes in Bilirubin Predict 90-Day Mortality in Patients With Hepatocellular Carcinoma and Acute Decompensations of Cirrhosis: The HCC-AD Score.
Oliver Moore et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.